11 Best Rising Penny Stocks to Buy According to Hedge Funds

Page 7 of 10

4. Esperion Therapeutics, Inc. (NASDAQ:ESPR)

Price: $2.17

1 Month Performance: 45.64%

Number of Hedge Fund Holders: 16

Esperion Therapeutics, Inc. (NASDAQ:ESPR) is one of the Best Rising Penny Stocks to Buy According to Hedge Funds. On August 5, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Esperion Therapeutics, Inc. (NASDAQ:ESPR) with a price target of $16.

The analyst noted that the company delivered robust performance during its fiscal second quarter of 2025 and beat Wall Street estimates for revenue and EPS. The company delivered a revenue of $82.39 million, reflecting 11.58% year-over-year growth and ahead of estimates by $19.34 million. The EPS of negative $0.02 also topped the consensus by $0.14.

Pantginis highlighted that Esperion Therapeutics, Inc. (NASDAQ:ESPR) saw a huge jump in US product revenue, especially from its NEXLETOL and NEXLIZET drugs. This was mainly driven by more retail prescriptions and higher use among patients who cannot tolerate statins.

Moreover, the company is also expanding globally and has secured approval for its BDA product in 40 countries, with more approvals expected soon.

Esperion Therapeutics, Inc. (NASDAQ:ESPR) develops and sells oral, once-daily, non-statin medicines for people at risk of cardiovascular disease with high LDL cholesterol.

Page 7 of 10